Relationship of individual cognitive abilities to specific components of decisional capacity among middle-aged and older patients with schizophrenia

Schizophrenia Bulletin

Volumn 32, Issue 1, 2006, Pages 98-106

  Palmer, Barton W ^a,b   Jeste, Dilip V ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

Bioethics; Competence; Informed consent; Neurocognition; Psychoses

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; COGNITION; COMPETENCE; CONTROLLED STUDY; CORRELATION ANALYSIS; DECISION MAKING; DEPRESSION; DISEASE SEVERITY; EDUCATION; FEMALE; HUMAN; INFORMED CONSENT; LEARNING; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; RATING SCALE; SCHIZOPHRENIA; SCORING SYSTEM; TASK PERFORMANCE; WECHSLER INTELLIGENCE SCALE; WISCONSIN CARD SORTING TEST; WORKING MEMORY;

ADULT; AGED; BIOETHICS; COGNITION DISORDERS; COMORBIDITY; DECISION MAKING; DISCLOSURE; HUMANS; INFORMED CONSENT; INTERVIEW, PSYCHOLOGICAL; MENTAL COMPETENCY; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; SCHIZOPHRENIA;

EID: 30344464681     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbj002     Document Type: Article

References (52)

1. Amador XF, Flaum M, Andreasen NC, Strauss DH, Yale SA, Clark SC, Gorman JM. Awareness of illness in schizophrenia and schizoaffective and mood disorders. Arch Gen Psychiatry. 1994;51:826-836.
2. Heinrichs RW, Zakzanis KK. Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology. 1998;12:426-445.
3. National Bioethics Advisory Commission. Research Involving Persons With Mental Disorders That May Affect Decision-Making Capacity. Rockville, Md: Report and Recommendations of the National Bioethics Advisory Commission; 1998.
4. Appelbaum PS, Roth LH. Competency to consent to research: a psychiatric overview. Arch Gen Psychiatry. 1982; 39:951-958.
5. Grisso T, Appelbaum PS. Assessing Competence to Consent to Treatment: A Guide for Physicians and Other Health Professionals. New York: Oxford University Press; 1998.
6. Palmer BW, Heaton RK, Paulsen JS, Kuck J, Braff D, Harris MJ, Zisook S, Jeste DV. Is it possible to be schizophrenic yet neuropsychologically normal? Neuropsychology. 1997;11:437-446.
7. Carpenter WT, Gold JM, Lahti AC, Queern CA, Conley RR, Bartko JJ, Kovnick J, Appelbaum PS. Decisional capacity for informed consent in schizophrenia research. Arch Gen Psychiatry. 2000;57:533-538.
8. Kovnick JA, Appelbaum PS, Hoge SK, Leadbetter RA. Competence to consent to research among long-stay inpatients with chronic schizophrenia. Psychiatr Serv. 2003;54:1247-1252.
9. Palmer BW, Dunn LB, Appelbaum PS, Jeste DV. Correlates of treatment-related decision-making capacity among middle-aged and older patients with schizophrenia. Arch Gen Psychiatry. 2004;61:230-236.
10. Palmer BW, Dunn LB, Appelbaum PS, Mudaliar S, Thal L, Henry R, Golshan S, Jeste DV. Assessment of capacity to consent to research among older persons with schizophrenia, Alzheimer disease, or diabetes mellitus: comparison of a three-item questionnaire with a comprehensive standardized capacity instrument. Arch Gen Psychiatry. 2005;62:726-733.
11. Moser D, Schultz S, Arndt S, Benjamin ML, Fleming FW, Brems CS, Paulsen JS, Appelbaum PS, Andreasen NC. Capacity to provide informed consent for participation in schizophrenia and HIV research. Am J Psychiatry. 2002;159:1201-1207.
12. Saks ER, Dunn LB, Marshall BJ, Nayak GV, Golshan S, Jeste DV. The California Scale of Appreciation: a new instrument to measure the appreciation component of capacity to consent to research. Am J Geriatr Psychiatry. 2002;10:166-174.
13. Heaton R, Paulsen J, McAdams LA, Kuck J, Zisook S, Braff D, Harris MJ, Jeste DV. Neuropsychological deficits in schizophrenia: relationship to age, chronicity and dementia. Arch Gen Psychiatry. 1994;51:469-476.
14. Marson DC, Chatterjee A, Ingram KK, Harrell LE. Toward a neurological model of competency: cognitive predictors of capacity to consent in Alzheimer's disease using three different legal standards. Neurology. 1996;46:666-672.
15. Green MF, Kern RS, Braff DL, Mintz J. Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"? Schizophr Bull. 2000;26:119-136.
16. Moser DJ, Reese RL, Schultz SK, Benjamin ML, Arndt S, Fleming FW, Andreasen NC. Informed consent in medication-free schizophrenia research. Am J Psychiatry. 2005;162:1209-1211.
17. Randolph C. RBANS - Manual - Repeatable Battery for the Assessment of Neuropsychological Status. San Antonio: Tex: Psychological Corporation; 1998.
18. Grisso T, Appelbaum PS. The MacArthur Treatment Competence Study. III. Abilities of patients to consent to psychiatric and medical treatments. Law Hum Behav. 1995;19:149-174.
19. Wechsler D. Wechsler Adult Intelligence Scale - Revised, manual. Cleveland, Ohio: Psychological Corporation; 1981.
20. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Research. 1975;12:189-198.
21. Mattis S. Dementia Rating Scale. Odessa, Fla: Psychological Assessment Resources, Inc.; 1973.
22. Christensen H, Kumar R. Cognitive changes and the ageing brain. In: Sachdev PS, ed. The Ageing Brain: The Neurobiology and Neuropsychiatry of Ageing. Lisse, Netherlands: Swets and Zeitlinger; 2003; 75-95.
23. Flory J, Emanuel E. Interventions to improve research participants' understanding in informed consent for research: a systematic review. JAMA. 2004;292:1593-1601.
24. American Psychiatric Association. Diagnostic Criteria from DSM-IV. Washington, DC: American Psychiatric Association; 1994.
25. Appelbaum PS, Grisso T. MacCAT-CR: MacArthur Competence Assessment Tool for Clinical Research. Sarasota, Fla: Professional Resource Press; 2001.
26. Kay S, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:261-276.
27. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967;6:278-296.
28. Birchwood M, Smith V, Drury V. A self-report insight scale for psychosis: reliability, validity and sensitivity to change. Acta Psychiatr Scand. 1994;89:62-67.
29. Dunn LM, Markwardt FC. Peabody Individual Achievement Tests. Circle Pines, Minn: American Guidance Service; 1970.
30. Benton AL, Hamsher KdeS, Sivan AB. Multilingual Aphasia Examination. 3d ed. Iowa City, Iowa: AJA Associates; 1994.
31. Wechsler D. Wechsler Adult Intelligence Scale - Third Edition (WAIS-III). San Antonio, Tex: Psychological Corporation; 1997.
32. Reitan RM, Wolfson D. The Halstead-Reitan Neuropsychological Test Battery: Theory and Clinical Interpretation. 2d ed. Tucson, Ariz: Neuropsychology Press; 1993.
33. Gladsjo JA, Schuman C, Evans J, Peavy G, Miller S, Heaton RK. Norms for letter and category fluency: demographic corrections for age, education, and ethnicity. Assessment. 1999;6:147-178.
34. Lezak MD, Howieson DB, Loring DW, Hannay HJ, Fisher JS. Neuropsychological Assessment. 4th ed. New York: Oxford University Press; 2004.
35. Kongs SK, Thompson LL, Iverson GL, Heaton RK. Wisconsin Card Sorting Test - 64 Card Version (WCST-64). Odessa, Fla: Psychological Assessment Resources; 2000.
36. Golden CJ, Freshwater SM. Stroop Color and Word Test: A Manual for Clinical and Experimental Uses. Wood Dale, Ill: Stoelting; 2002.
37. Benedict RHB, Schretlen D, Groninger L, Brandt J. Hopkins Verbal Learning Test - Revised: normative data and analysis of inter-form and test-retest reliability. Clin Neuropsychol. 1998;12:43-55.
38. Heaton RK, Miller SW, Taylor MJ, Grant I. Revised Comprehensive Norms for an Expanded Halstead-Reitan Battery: Demographically Adjusted Neuropsychological Norms for African American and Caucasian Adults. Lutz, Fla: Psychological Assessment Resources; 2004.
39. Benedict RHB. Brief Visual-Spatial Memory Test - Revised. Professional Manual. Odessa, Fla: Psychological Assessment Resources; 1997.
40. Wechsler D. Wechsler Adult Intelligence Scale (Third Edition): Administration and Scoring Manual. San Antonio, Tex: Psychological Corporation; 1997.
41. Gladsjo JA, McAdams LA, Palmer BW, Moore D, Jeste DV, Heaton RK. A six-factor model of cognition in schizophrenia and related psychotic disorders: relationships with clinical symptoms and functional capacity. Schizophr Bull. 2004;30:739-754.
42. Tulsky DS, Ivnik RJ, Price LR, Wilkins C. Assessment of cognitive functioning with the WAIS-III and WMS-III: development of a six-factor model. In: Tulsky D, Saklofske D, Heaton RK, Chelune G, Ivnik R, Bornstein RA, Prifitera A, Ledbetter B, eds. Clinical Interpretation of the WAIS-III and the WMS-III. San Diego, Calif: Academic Press; 2003: 145-177.
43. Green MF. What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry. 1996;153:321-330.
44. Palmer BW, Heaton RK, Gladsjo JA, Evan JD, Patterson TL, Golshan S, Jeste DV. Heterogeneity in functional status among older outpatients with schizophrenia: employment history, living situation, and driving. Schizophr Res. 2002;55:205-215.
45. Dunn LB, Nowrangi MA, Palmer BW, Jeste DV, Saks ER. Assessing decisional capacity for clinical research or treatment: a review of instruments. Am J Psychiatry. 2005;in press.
46. Kim SYH, Caine ED, Currier GW, Leibovici A, Ryan JM. Assessing the competence of persons with Alzheimer's disease in providing informed consent for participation in research. Am J Psychiatry. 2001;158:712-717.
47. Jeste DV, Depp CA, Palmer BW. Magnitude of impairment in decisional capacity in people with schizophrenia compared to normal subjects: an overview. Schizophr Bull. 2005;in press.
48. Cohen CI, Cohen GD, Blank K, Gaitz C, Katz IR, Leuchter A, Maletta G, Meyers B, Sakauye K, Shamoian C. Schizophrenia and older adults: an overview: directions for research and policy. Am J Geriatr Psychiatry. 2000;8:19-28.
49. Dunn LB, Lindamer LA, Palmer BW, Golshan S, Schneiderman LJ, Jeste DV. Improving understanding of research consent in middle-aged and elderly patients with psychotic disorders. Am J Geriatr Psychiatry. 2002;10:142-150.
50. Dunn LB, Jeste DV. Enhancing informed consent for research and treatment. Neuropsychopharmacology. 2001;24:595-607.
51. Wirshing DA, Wirshing WC, Marder SR, Liberman RP, Mintz J. Informed consent: assessment of comprehension. Am J Psychiatry. 1998;155:1508-1511.
52. Roberts LW, Warner TD, Brody JL. Perspectives of patients with schizophrenia and psychiatrists regarding ethically important aspects of research participation. Am J Psychiatry. 2000;157:67-74.